Viking Therapeutics (VKTX)
(Delayed Data from NSDQ)
$57.00 USD
-1.20 (-2.06%)
Updated Aug 15, 2024 04:00 PM ET
Pre-Market: $57.00 0.00 (0.00%) 8:22 AM ET
3-Hold of 5 3
C Value D Growth B Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
10/23/2024
Time: -- |
9/2024 | $-0.24 | -0.06% |
Earnings Summary
For their last quarter, Viking Therapeutics (VKTX) reported earnings of -$0.20 per share, beating the Zacks Consensus Estimate of $-0.26 per share. This reflects a positive earnings surprise of 23.08%. Look out for VKTX's next earnings release expected on October 23, 2024. For the next earning release, we expect the company to report earnings of -$0.24 per share, reflecting a year-over-year decrease of 4.35%.
Earnings History
Price & Consensus
Zacks News for VKTX
Viking (VKTX) Q2 Earnings Beat, Stock Up on Pipeline Updates
VKTX: What are Zacks experts saying now?
Zacks Private Portfolio Services